J.O. Park

机构：Samsung Medical Center

发表论文 3 篇 · 总被引 7 次 · h-index 2

代表论文

• 79TiP A phase II/III, randomized, placebo-controlled study of bintrafusp alfa with gemcitabine plus cisplatin as first-line treatment of biliary tract cancer (2020 · Annals of Oncology · 被引 4)
• 384TiP Quemliclustat and chemotherapy in previously untreated patients with metastatic pancreatic ductal adenocarcinoma: PRISM-1, a randomized, placebo-controlled, phase III trial (2025 · Annals of Oncology · 被引 3)
• 133O Safety of 30 min infusion of durvalumab (D) in combination with gemcitabine (G)-based chemotherapy in first-line treatment (tx) of advanced biliary tract cancer (aBTC): TOURMALINE early results (2024 · Annals of Oncology)